The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Explained and Unexplained Ischemic Heart Disease Risk after Renal Transplantation
Abstract
: Whether the high incidence of ischemic heart disease (IHD) among renal transplant patients can be attributed to the same risk factors that have been identified in the general population is unclear. The risk for major IHD events occurring >1 yr after transplantation among 1124 transplant recipients was estimated by using the risk calculated from the Framingham Heart Study (FHS). The FHS risk predicted IHD (relative risk, 1.28; 95% confidence interval, 1.20 to 1.40; P < 0.001); however, the FHS risk tended to underestimate the risk of IHD for renal transplant recipients. This was largely attributable to increased risks associated with diabetes mellitus and, to a lesser extent, age and cigarette smoking for renal transplant recipients. For men, the relative risks for diabetes mellitus were 2.78 (1.73 to 4.49) and 1.53 for the transplant recipient and FHS populations, respectively; the relative risks for age (in years) were 1.06 (1.04 to 1.08) and 1.05, respectively, and those for smoking were 1.95 (1.20 to 3.19) and 1.69, respectively. For women, the relative risks for diabetes mellitus were 5.40 (2.73 to 10.66) and 1.82, respectively. There was a tendency for the risk associated with cholesterol levels to be higher for transplant recipients, compared with the FHS population, but the risks associated with high-density lipoprotein cholesterol levels and BP appeared to be comparable. Independent of these and other risk factors, the adjusted risk of IHD for the transplant recipient population has decreased. Compared with the era before 1986, transplantation between 1986 and 1992 was associated with a lower relative risk of 0.60 (0.39 to 0.92); transplantation after 1992 was associated with an even lower relative risk of 0.27 (0.11 to 0.63) for IHD. Of concern was the fact that dihydropyridine calcium channel antagonists were associated with an increased risk for IHD (relative risk, 2.26; 95% confidence interval, 1.24 to 4.12; P = 0.008), and this association was independent of other antihypertensive agents and risk factors. Therefore, although the FHS risk predicts IHD after renal transplantation, it tends to underestimate the risks, especially the risk associated with diabetes mellitus. The unexpected finding that dihydropyridine calcium channel antagonists were associated with an increased IHD risk merits further evaluation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
Nifedipine: Dose-Related Increase in Mortality in Patients With Coronary Heart Disease
Furberg, C. D., Psaty, B. M., & Meyer, J. V. (1995) · Circulation · doi:10.1161/01.cir.92.5.1326 · Cited by 1,173
Estacio, R. O., Jeffers, B. W., Hiatt, W. R., Biggerstaff, S. L., Gifford, N., & Schrier, R. W. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803053381003 · Cited by 1,166
Cardiovascular disease after renal transplantation.
Kasiske, B. L., Guijarro, C., Massy, Z. A., Wiederkehr, M. R., & Ma, J. Z. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v71158 · Cited by 669
Self-citationRisk factors for accelerated atherosclerosis in renal transplant recipients
Kasiske, B. L. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90302-6 · Cited by 358
Self-citationPLASMA TRIGLYCERIDE AS A RISK FACTOR FOR CORONARY HEART DISEASE
AUSTIN, M. A. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115130 · Cited by 352
Epidemiology of triglycerides: A view from Framingham
Castelli, W. P. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91083-g · Cited by 346
LINDHOLM, A., ALBRECHTSEN, D., FRÖDIN, L., TUFVESON, G., PERSSON, N. H., & LUNDGREN, G. (1995) · Transplantation · doi:10.1097/00007890-199509000-00008 · Cited by 330
Controlling the epidemic of cardiovascular disease in chronic renal disease: Where do we start?
Levey, A. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820463 · Cited by 171
de Champlain, J., Karas, M. G., Nguyen, P., Cartier, P., Wistaff, R., Toal, C. B., Nadeau, R. A., & Larochelle, P. M. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816090-00017 · Cited by 104
Calcium-Channel Blockers for Hypertension — Uncertainty Continues
Cutler, J. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803053381009 · Cited by 89
Stroke in Renal Transplant Recipients
Adams, H. P., Dawson, G., Coffman, T. J., et al. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520020007006 · Cited by 74
Carotid atherosclerosis in renal transplant recipients
Massy, Z. A. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.7.1792 · Cited by 47
Michels, K. B., ROSNER, B. A., Manson, J. E., Stampfer, M. J., Walker, A. M., Willett, W. C., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.97.16.1540 · Cited by 41
Safety of Nifedipine in Angina Pectoris
Stason, W. B., Schmid, C. H., Niedzwiecki, D., Whiting, G. W., Caubet, J.-F., Cory, D., Luo, D., Ross, S. D., & Chalmers, T. C. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.24 · Cited by 40
Cited by
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
Self-citationSpecial Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Eckardt, K.-U., Kasiske, B. L., & Zeier, M. G. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02834.x · Cited by 1,499
Self-citationSarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000102971.85504.7c · Cited by 1,144
Self-citationHoldaas, H., Fellström, B., Jardine, A. G., Holme, I., Nyberg, G., Fauchald, P., Grönhagen-Riska, C., Madsen, S., Neumayer, H.-H., Cole, E., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13638-0 · Cited by 919
Strategies to Improve Long-Term Outcomes after Renal Transplantation
Pascual, M., Theruvath, T., Kawai, T., Tolkoff-Rubin, N., & Cosimi, A. B. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011295 · Cited by 844
Metadata
- Authors
- KASISKE, B. L., CHAKKERA, H. A., & ROEL, J.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2000-09
- Volume
- 11
- Issue
- 9
- Pages
- 1735-1743
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2253134880
- Cited by
- 506
- References
- 17
- FWCI
- 12.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.